Ranolazine (RS-43285): A preliminary study of a new anti-anginal agent with selective effect on ischaemic myocardium

European Journal of Clinical Pharmacology

Volumn 38, Issue 2, 1990, Pages 111-114

  Jain, D ^a   Dasgupta, P ^a   Hughes, L O ^a   Lahiri, A ^a   Raftery, E B ^a  

^a NORTHWICK PARK HOSPITAL   (United Kingdom)

Author keywords

angina; Ranolazine; stress testing

Indexed keywords

PLACEBO; RANOLAZINE;

ADULT; AGED; ANGINA PECTORIS; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED STUDY; EXERCISE TEST; FEMALE; HEMODYNAMICS; HUMAN; MALE; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL;

ANGINA PECTORIS; ANIMAL; BLOOD PRESSURE; CORONARY DISEASE; ELECTROCARDIOGRAPHY; EXERCISE TEST; HEART RATE; NITROGLYCERIN; PIPERAZINES; SINGLE-BLIND METHOD; SUPPORT, NON-U.S. GOV'T;

EID: 0025217267     PISSN: 00316970     EISSN: 14321041     Source Type: Journal    
DOI: 10.1007/BF00265967     Document Type: Article

References (7)

1. Comparison of the effects of a series of antianginal agents in a novel canine model of transient myocardial ischaemia
2. The effects of the novel anti-anginal agent RS-43285 on lactic acid, K+ and pH in a canine model of transient myocardial ischaemia
3. Long term anti-anginal action of Verapamil assessed using quantitative serial treadmill stress testing
4. Standards for adult exercise testing laboratories
5. Verapamil in chronic stable angina. A controlled study with computerized multistage treadmill exercise